• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Pediatric Hemodialysis Study Finds No Significant Hemoglobin Difference Between Iron Routes

by
November 12, 2026
in Health
Reading Time: 3 mins read
0
Pediatric Hemodialysis Study Finds No Significant Hemoglobin Difference Between Iron Routes

Pediatric Hemodialysis Study Finds No Significant Hemoglobin Difference Between Iron Routes

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In a two-center retrospective cohort study evaluating children undergoing maintenance hemodialysis, researchers found no statistically detectable difference in six-month adjusted hemoglobin levels between patients receiving oral iron and those treated with intravenous iron supplementation. The investigation evaluated whether the route of iron administration influenced hematologic recovery and iron-status parameters over a six-month observation window among thirty pediatric patients.

Anemia represents a frequent and clinically significant complication in pediatric patients diagnosed with chronic kidney disease, particularly among individuals requiring regular maintenance hemodialysis. While supplemental iron therapy is recognized as essential for optimizing erythropoiesis in this clinical cohort, the optimal route of administration—comparing oral versus intravenous regimens—has remained an ongoing subject of debate within pediatric nephrology practice.

Conducted across two tertiary medical centers, the retrospective study examined thirty pediatric maintenance-hemodialysis patients who were administered individualized iron regimens based on the clinical discretion of their treating physicians. Among the overall cohort, fifteen children were assigned to receive intravenous iron supplementation, while the remaining fifteen children received oral iron therapy under individualized management protocols.

The primary endpoint of the investigation was hemoglobin concentration measured at six months, analyzed through analysis of covariance comparing oral with intravenous iron while adjusting for baseline hemoglobin, dialysis vintage, and log-transformed baseline C-reactive protein using HC3 robust standard errors. Across unadjusted evaluations, mean hemoglobin rose by 0.67 ± 1.76 g/dL in the intravenous iron cohort and by 1.76 ± 2.45 g/dL in the oral iron cohort, reflecting a direct between-group difference in change of 1.09 g/dL with a 95% confidence interval ranging from −0.52 to 2.69 g/dL (P = 0.175). In the primary adjusted analysis encompassing twenty-eight patients with complete data, the oral-minus-intravenous difference in six-month hemoglobin was 1.31 g/dL with a 95% confidence interval of −0.56 to 3.18 g/dL (P = 0.161), and all corresponding sensitivity analyses similarly yielded non-significant findings.

Secondary outcomes assessed across the six-month study period included serum ferritin, transferrin saturation, other iron-status indices, epoetin alfa utilization, treatment-related complications, and packed-cell blood transfusions. Serum ferritin concentrations demonstrated increases within both treatment arms, though the between-group difference in change did not achieve statistical significance. While an exploratory unadjusted change-score calculation suggested a greater increase in transferrin saturation among oral iron recipients, this baseline-adjusted comparison did not remain statistically significant following false-discovery-rate correction. Complications were documented in eight of fifteen oral iron recipients and seven of fifteen intravenous recipients (P = 1.000), packed-cell transfusions were administered to two oral iron patients and six intravenous iron patients (P = 0.215), and no serious adverse events were documented in either group.

In their concluding assessment, the study authors emphasized that the observed lack of a statistically detectable difference in adjusted six-month hemoglobin must be interpreted with caution. The small overall cohort size, wide confidence intervals, baseline imbalances between arms, individualized treatment selection by treating clinicians, and the potential presence of residual confounding preclude definitive conclusions regarding the superiority, clinical equivalence, or preferred route of iron administration in pediatric hemodialysis care.

Subject of Research: Oral versus intravenous iron supplementation outcomes in pediatric hemodialysis

Article Title: Oral versus intravenous iron supplementation and six-month hemoglobin and iron-status outcomes in pediatric hemodialysis: a two-center retrospective cohort study

Article References: Voshtani, S., Bahroudi, M., Mojtahedi, S. Y., Moghtaderi, M., Safari, A., Fahimi, D., Askarian, F., Abbasi, A., & Bazargani, B. (2026). Oral versus intravenous iron supplementation and six-month hemoglobin and iron-status outcomes in pediatric hemodialysis: a two-center retrospective cohort study. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07834-y

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07834-y

Keywords: pediatric hemodialysis, oral iron, intravenous iron, chronic kidney disease, anemia, hemoglobin, ferritin, transferrin saturation, erythropoiesis, epoetin alfa, dialysis vintage, C-reactive protein, packed-cell transfusion, retrospective cohort study, tertiary centers, iron supplementation

News Source: Harold Sullivan. (November 12, 2026). Pediatric Hemodialysis Study Finds No Significant Hemoglobin Difference Between Iron Routes. Scienmag.

Tags: anemiaC-reactive proteinChronic Kidney Diseasedialysis vintageepoetin alfaerythropoiesisferritinhemoglobinintravenous ironiron supplementationoral ironpacked-cell transfusionpediatric hemodialysisretrospective cohort studytertiary centersTransferrin saturation
Share12Tweet7Share2ShareShareShare1

Related Posts

One Distal Screw Matches Two in Humeral Nailing Functional Outcomes

One Distal Screw Matches Two in Humeral Nailing Functional Outcomes

November 20, 2026
Adipose CD248 Rises in Obesity and Responds Directly to Glucocorticoids

Adipose CD248 Rises in Obesity and Responds Directly to Glucocorticoids

November 20, 2026

Sri Lankan Study Tracks Early Outcomes and Complications Following NICU Discharge

November 20, 2026

Parkinson’s Disease Patients Show Flexible Axial Coordination During Full Circle Turns

November 20, 2026

POPULAR NEWS

  • One Distal Screw Matches Two in Humeral Nailing Functional Outcomes

    One Distal Screw Matches Two in Humeral Nailing Functional Outcomes

    29 shares
    Share 12 Tweet 7
  • Adipose CD248 Rises in Obesity and Responds Directly to Glucocorticoids

    29 shares
    Share 12 Tweet 7
  • Predictable Human Food Prompts Alpine Choughs to Undertake Daily Routine Altitudinal Flights

    29 shares
    Share 12 Tweet 7
  • Alien Plant Spatial Metrics Vary in Reliability Under Simulated Incomplete Sampling

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

One Distal Screw Matches Two in Humeral Nailing Functional Outcomes

Adipose CD248 Rises in Obesity and Responds Directly to Glucocorticoids

Predictable Human Food Prompts Alpine Choughs to Undertake Daily Routine Altitudinal Flights

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.